JNJ

Gilead Sciences and Johnson & Johnson Push Vertex Out of Hepatitis C Race
Motley Fool
Sun, 11/3/13 - 12:06 pm
Gilead Sciences
JNJ
Vertex Pharmaceuticals
hepatitis
hepatitis B
This Week in Biotech: Twitter Edition
Motley Fool
Sat, 11/2/13 - 11:36 am
Gilead Sciences
PDL Biopharma
Depomed
Vertex Pharmaceuticals
JNJ
Sarepta Therapeutics
When Japanese Pharma Report, These American Biotechs React
Motley Fool
Sat, 11/2/13 - 11:22 am
Arena Pharmaceuticals
Medivation
JNJ
Vivus
Astellas
Eisai
Cheaper By The Dozen? J&J Is Sued Over 340B Drug Discounts
Pharmalot
Fri, 11/1/13 - 09:51 am
JNJ
340B
drug discounts
J&J's Janssen Must Pay $4 Million Over Topamax, Jury Says
Bloomberg
Wed, 10/30/13 - 08:45 pm
Topamax
JNJ
Why Gilead's Sofosbuvir Is Better Than J&J's Simeprevir
Motley Fool
Tue, 10/29/13 - 09:21 am
Gilead
sofosbuvir
JNJ
hepatitis C
simeprevir
J&J Is Curiously Absent From Twitter -- Does That Matter?
Advertising Age
Mon, 10/28/13 - 09:31 am
JNJ
twitter
social media
J&J-Medivir Hepatitis C Pills Wins U.S. Panel Backing
Bloomberg
Thu, 10/24/13 - 06:04 pm
FDA
JNJ
Medivir
hepatitis C
simeprevir
Diabetes Giants Battle Outside of Their Usual Arena
Motley Fool
Thu, 10/24/13 - 11:29 am
Novo Nordisk
diabetes
Merck
Sanofi
NovoSeven
JNJ
Bristol-Myers Squibb - There Is Life After Plavix
Seeking Alpha
Thu, 10/24/13 - 10:19 am
Plavix
Bristol-Myers Squibb
JNJ
PFE
Johnson & Johnson's Hidden Source Of Value
Seeking Alpha
Wed, 10/23/13 - 06:31 pm
JNJ
J&J-Medivir’s Drug Works Against Hepatitis C
Bloomberg
Tue, 10/22/13 - 08:36 am
JNJ
Medivir
hepatitis C
simeprevir
FDA
The 3 Best-Selling Drugs in the World
Motley Fool
Mon, 10/21/13 - 08:24 am
AbbVie
Humira
Remicade
JNJ
GSK
Advair
Johnson & Johnson Continues To Ride The Success Of Its Immunology And Oncology Drugs
Seeking Alpha
Fri, 10/18/13 - 10:07 am
JNJ
Remicade
Simponi
Stelara
Invokana
Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline
Fierce Biotech
Thu, 10/17/13 - 06:18 pm
Cleveland Clinic
JNJ
Pharmacyclics
Novartis
serelaxin
ibrutinib
sofosbuvir
Gilead
Can The First Malaria Vaccine Drive GlaxoSmithKline's Growth?
Seeking Alpha
Wed, 10/16/13 - 08:35 am
GSK
vaccines
malaria
Agenus
Daiichi Sankyo
RTS,S
JNJ
Janssen's Topamax Users Blame Drug for Birth Defects
Bloomberg
Tue, 10/15/13 - 04:58 pm
Janssen
Topamax
JNJ
birth defects
3 Ways Q3 Results Show How J&J Is Dramatically Changing
Motley Fool
Tue, 10/15/13 - 04:57 pm
JNJ
earnings
Johnson & Johnson Profit Beats Estimates on Drug Sales
Bloomberg
Tue, 10/15/13 - 08:37 am
earnings
JNJ
McClellan To The Rescue? J&J Adds Former FDA Commish On Board
Pharmalot
Mon, 10/14/13 - 11:41 am
JNJ
FDA
Mark McClellan

Pages